Akero Therapeutics, Inc.

NEW YORK STATE COMMON RETIREMENT FUND AKRO

Report date

9/30/2025

Quarter

2025 Q3

Filed

11/3/2025

Shares

33,196

Value ($000)

1,576

Weight

0.0%

2019 Q4 - 2025 Q3 (24 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q3	11/3/2025	1,576	0.0%	33,196	9/30/2025
2025 Q2	10/8/2025	1,486	0.0%	27,849	6/30/2025
2025 Q1	10/8/2025	851	0.0%	21,013	3/31/2025
2024 Q4	10/8/2025	585	0.0%	21,013	12/31/2024
2024 Q3	10/8/2025	603	0.0%	21,013	9/30/2024
2024 Q2	10/8/2025	706	0.0%	30,078	6/30/2024
2024 Q1	10/8/2025	877	0.0%	34,738	3/31/2024
2023 Q4	10/8/2025	807	0.0%	34,545	12/31/2023
2023 Q3	10/8/2025	1,686	0.0%	33,331	9/30/2023
2023 Q2	10/8/2025	1,269	0.0%	27,172	6/30/2023
2023 Q1	10/8/2025	1,059	0.0%	27,682	3/31/2023
2022 Q4	10/8/2025	1,788	0.0%	32,629	12/31/2022
2022 Q3	11/8/2022	689	0.0%	20,237	9/30/2022
2022 Q2	8/4/2022	172	0.0%	18,182	6/30/2022
2022 Q1	7/1/2022	259	0.0%	18,222	3/31/2022
2021 Q4	2/2/2022	385	0.0%	18,197	12/31/2021
2021 Q3	11/2/2021	408	0.0%	18,266	9/30/2021
2021 Q2	8/2/2021	548	0.0%	22,104	6/30/2021
2021 Q1	5/11/2021	389	0.0%	13,400	3/31/2021
2020 Q4	2/8/2021	346	0.0%	13,400	12/31/2020
2020 Q3	11/5/2020	311	0.0%	10,100	9/30/2020
2020 Q2	8/7/2020	252	0.0%	10,100	6/30/2020
2020 Q1	5/6/2020	112	0.0%	5,300	3/31/2020
2019 Q4	2/5/2020	118	0.0%	5,300	12/31/2019